The normal expression of human beta-globin is crucially dependent upon the high stability of its encoding mRNA.? Despite the clear importance of this property, relatively little is known about the structural determinants of beta-? globin mRNA stability or the manner in which the,,' contribute to regulated 13-globin gene expression. The? current proposal is designed to establish a comprehensive understanding of the structures, factors, and? mechanisms that effect the high stability of human lg-globin mRNA. The research is a collaborative effort that? partners mechanistic and functional approaches, permitting cell culture and in vitro analyses to be confirmed'in? physiologically-meaningful animal models. The proposed experimental plan comprises three specific aims? designed to confirm and extend a substantial body of relevant preliminary data.
Specific Aim I will map? sequences within the beta-globin mRNA that are crucial to its high stability. The mRNA-destabilizing effects of? mutations blanketing the 3'UTR will be screened in cultured erythroid cells, and their physiological effects? confirmed in intact transgenic animals.
Specific Aim II will identify trans-acting cytoplasmic factors that? interact with relevant mRNA cis-elements. The factor(s) will be purified from erythroid cell lysate using a? hover affinity chromatographic method, and identified using conventional techniques. In addition, cytoplasmic? factors that are known to stabilize ct-globin mRNA will be directly tested for their effect on beta-globin mRNA? stability.
Specific Aim HI will define the mechanism(s) through which beta-globin mRNA stability is maintained.? The functional properties of the purified trans-acting factors will be demonstrated using an established in vitro? method that wiII be specifically adapted for this purpose. Related in vitro analyses will define the initial and? subsequent steps in beta-globin mRNA decay, with special atten:ion to the importance of the poly(A) tail and the? potential role of an erythroid cell-specific endoribonuclease. The successful completion of the proposed? research will provide new insights into the control of ig-globin gene expression by establishing a fundamental? understanding of the factors and mechanisms that contribute to lg-globin mRNA stability, A detailed knowledge? of these basic processes will facilitate design of novel therapies that modify expression of 13s and other 13-like? globins, including globins encoded by both endogenous and transduced genes, by manipulating the stabilities of? their cognate mRNAs.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54HL070596-01
Application #
7527771
Study Section
Special Emphasis Panel (ZHL1-CSR-F (S1))
Project Start
2003-07-22
Project End
2008-03-31
Budget Start
2003-07-22
Budget End
2004-03-31
Support Year
1
Fiscal Year
2003
Total Cost
$153,070
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Wrotniak, Brian H; Schall, Joan I; Brault, Megan E et al. (2014) Health-related quality of life in children with sickle cell disease using the child health questionnaire. J Pediatr Health Care 28:14-22
Dougherty, Kelly A; Schall, Joan I; Kawchak, Deborah A et al. (2012) No improvement in suboptimal vitamin A status with a randomized, double-blind, placebo-controlled trial of vitamin A supplementation in children with sickle cell disease. Am J Clin Nutr 96:932-40
Dougherty, Kelly A; Schall, Joan I; Rovner, Alisha J et al. (2011) Attenuated maximal muscle strength and peak power in children with sickle cell disease. J Pediatr Hematol Oncol 33:93-7
Abdulmalik, Osheiza; Safo, Martin K; Seeholzer, Steven H et al. (2010) Hb Baden: structural and functional characterization. Am J Hematol 85:848-52
Enninful-Eghan, Henrietta; Moore, ReneƩ H; Ichord, Rebecca et al. (2010) Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease. J Pediatr 157:479-84
Schwartz, Lisa A; Radcliffe, Jerilynn; Barakat, Lamia P (2009) Associates of school absenteeism in adolescents with sickle cell disease. Pediatr Blood Cancer 52:92-6
Peranteau, William H; Heaton, Todd E; Gu, Yu-Chen et al. (2009) Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model. Biol Blood Marrow Transplant 15:293-305
Adachi, Kazuhiko; Ding, Min; Asakura, Toshio et al. (2009) Relationship between beta4 hydrogen bond and beta6 hydrophobic interactions during aggregate, fiber or crystal formation in oversaturated solutions of hemoglobin A and S. Arch Biochem Biophys 481:137-44
Rovner, Alisha J; Stallings, Virginia A; Kawchak, Deborah A et al. (2008) High risk of vitamin D deficiency in children with sickle cell disease. J Am Diet Assoc 108:1512-6
Adachi, Kazuhiko; Ding, Min; Surrey, Saul (2008) Role of the beta4Thr-beta73Asp hydrogen bond in HbS polymer and domain formation from multinucleate-containing clusters. Biochemistry 47:5441-9

Showing the most recent 10 out of 23 publications